Pharma Journalist 8791 posts 0 comments

AstraZeneca announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for Calquence (acalabrutinib) as a monotherapy treatment for…
Read More...

AstraZeneca and MSD Inc., Kenilworth, N.J., US (MSD: known as Merck & Co., Inc. inside the US and Canada) announced positive results from the Phase III PAOLA-1 trial in women with…
Read More...

The Janssen Pharmaceutical Companies of Johnson & Johnson announced that the European Commission (EC) has approved variations to broaden the use of Imbruvica (ibrutinib) in two…
Read More...

Eli Lilly and Company announced Taltz (ixekizumab) met the primary and all major secondary endpoints up to week 12 in the Phase 4 IXORA-R study, which evaluated the efficacy and safety…
Read More...

AskBio, the world's foremost clinical stage and gene therapy platform company, has acquired Synpromics, the leader in gene control synthetic promoter technology, bioinformatics and…
Read More...

CureVac AG, a fully integrated biopharmaceutical company pioneering the field of mRNA-based drugs, announced it has entered into a Collaborative Research Agreement (“CRA”) with Yale…
Read More...

SMi Reports: Inaugural conference set to explore contamination control in pharmaceutical aseptic manufacturing using cleanroom and barrier technologies this October The inaugural…
Read More...

Ascletis Pharma Inc. (1672.HK), an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, cancer and…
Read More...

Eidos Therapeutics, Inc. confirmed that it has received a non-binding proposal dated August 8, 2019 from BridgeBio Pharma, Inc., the parent entity of the Company’s majority stockholder,…
Read More...

Onconova Therapeutics announced that they have formed a collaboration to utilize the Mission Bio Tapestri Platform for targeted single-cell DNA analysis to study Onconova’s novel cancer…
Read More...